about
Current strategies to treat tuberculosisUrine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept studyEvaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children.Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antituberculosis drugs in children.
@en
type
label
Antituberculosis drugs in children.
@en
prefLabel
Antituberculosis drugs in children.
@en
P2860
P356
P1476
Antituberculosis drugs in children.
@en
P2093
P R Donald
P2860
P304
P356
10.1002/CPT.164
P407
P577
2015-06-10T00:00:00Z